Literature DB >> 10434407

A new anti-HBeAg lignan, kadsumarin A, from Kadsura matsudai and Schizandra arisanensis.

Y H Kuo1, S Y Li, M D Wu, R L Huang, L M Yang Kuo, C F Chen.   

Abstract

A new C18 dibenzocyclooctadiene lignan, kadsumarin A (1) was isolated from Kadsura matsudai Hayata and Schizandra arisanensis Hayata. The anti-HBeAg test revealed that kadsumarin A had activity at a concentration of 40 micrograms/ml (= 90.1 microM). Its structural elucidation by spectral analysis was discussed in this note.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10434407     DOI: 10.1248/cpb.47.1047

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  Schizandra arisanensis extract attenuates cytokine-mediated cytotoxicity in insulin-secreting cells.

Authors:  Yi-Shin Hsu; Yao-Haur Kuo; Hui-Ling Cheng; Peter R Flatt; Hui-Kang Liu
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

2.  A Comprehensive Comparative Study for the Authentication of the Kadsura Crude Drug.

Authors:  Jiushi Liu; Xueping Wei; Xiaoyi Zhang; Yaodong Qi; Bengang Zhang; Haitao Liu; Peigen Xiao
Journal:  Front Pharmacol       Date:  2019-01-22       Impact factor: 5.810

Review 3.  Plant-derived lignans as potential antiviral agents: a systematic review.

Authors:  Xin-Ya Xu; Dong-Ying Wang; Yi-Ping Li; Stephen T Deyrup; Hong-Jie Zhang
Journal:  Phytochem Rev       Date:  2021-05-31       Impact factor: 7.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.